Intel’s news source for media, analysts and everyone curious about the company.

El equipo de Intel y Google Cloud se unen al programa de investigación All of Us (English Only)

Intel today joins the National Institutes of Health All of Us Research Program to improve population health by making biomedical data from underrepresented groups available to COVID-19 researchers nationwide via the Researcher Workbench. (Credit: NIH All of Us Research Program)

What’s New: Intel today joins the National Institutes of Health (NIH) All of Us Research Program in its historic effort to improve population health by making biomedical data from underrepresented groups available to COVID-19 researchers nationwide via the Researcher Workbench. With a goal of recruiting 1 million U.S. participants from different backgrounds, All of Us is on track to build the most diverse health database of its kind and become one of the largest health research efforts in U.S. history.

“The ability to manage, analyze and share data at scale will be critical in this effort to deliver equitable and effective care during the COVID-19 pandemic and beyond. We are proud to support this important effort in partnership with All of Us and Intel.”
–Mike Daniels, vice president of Global Public Sector at Google Cloud

Why It Matters: Driven by the belief that diversity is key to accelerating health research and better understanding health disparities, the All of Us Research Program aims to enable thousands of studies on a wide range of diseases, including COVID-19. The program’s Researcher Workbench data repository will help researchers learn more about the impact of individual differences in lifestyle, socioeconomic, environment and biologic characteristics in order to advance precision diagnosis, prevention and treatment.

“All of Us is dedicated to serving a diverse body of researchers who can come together to tackle our most pressing health challenges,” said Chris Lunt, the chief technology officer of the NIH All of Us Research Program. “We appreciate Intel’s contribution of research credits and Google Cloud’s computing power to enable novel analysis of our dataset to drive greater understanding of COVID-19.”

To date, the program has enrolled more than 366,000 participants and received more than 279,000 biosamples for genomic sequencing, as well as amassed data from more than 233,000 electronic health records (EHRs) and more than 1.34 million completed surveys.

How the Program Works: Already, 80% of participants who completed early steps of the program are from underrepresented groups, including racial and ethnic minorities, those with an annual household income at or below 200% of the federal poverty level and those who have a cognitive or physical disability, to name a few. Participants are asked to answer health questionnaires, provide access to EHRs, give physical measurements, and agree to collection and analysis of biospecimens for genomic assessment.

To speed COVID-19 research, the program is prioritizing performing assays of serum collected between January 2020 and March 2020 to detect antibodies; collecting electronic health data from participants, including those who have tested or are presumed positive for COVID-19; and collecting data from recurring surveys about participants’ experiences during the pandemic. This biomedical data will be made broadly accessible to researchers through the Researcher Workbench, hosted on Google Cloud and powered by Intel® Xeon® Scalable processors. To assist in this effort, Intel is funding compute credits to support data curation and research projects to speed COVID-19 discovery and treatment.

“We are excited to join Google and All of Us in offering compute for analyzing the most diverse health database in the world,” said Prashant Shah, global head of artificial intelligence for Health and Life Sciences at Intel. “The collection and availability of this data is essential to speed scientific research and discovery to not only fight COVID-19, but to also address health disparities in medical research for years to come.”

About Intel’s Healthcare and COVID-19 Response: Intel is committed to accelerating access to technology that can combat the current pandemic and enable scientific discovery that better prepares our world for future crises. Support for NIH’s All of Us Research Program was provided in part by Intel’s Pandemic Response Technology Initiative.

More Context: Information about healthcare solutions from Intel | Information about Intel’s COVID-19 response

Acerca de Intel

Intel (Nasdaq: INTC) es una empresa líder en la industria, creando tecnología que cambia al mundo, habilita el progreso mundial y enriquece vidas. Inspirados en la Ley de Moore, continuamente avanzamos en el diseño y la fabricación de semiconductores para ayudar a enfrentar los desafíos más grandes de nuestros clientes. Al integrar inteligencia en la nube, las redes, el edge y toda clase de dispositivos de cómputo, liberamos el potencial de los datos para transformar y mejorar a las empresas y la sociedad. Si deseas conocer más sobre las innovaciones de Intel, visita e

© Intel Corporation, Intel, el logotipo de Intel y otras marcas de Intel son marcas registradas de Intel Corporation o sus subsidiarias. Otros nombres y marcas pueden ser reclamados como propiedad de otros.